Suppr超能文献

肠道菌群与甲状腺在健康与疾病中的相互作用

Microbiota and Thyroid Interaction in Health and Disease.

机构信息

Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany; Center for Medical Research, Medical University of Graz, Graz, Austria.

Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tuebingen, Tuebingen, Germany.

出版信息

Trends Endocrinol Metab. 2019 Aug;30(8):479-490. doi: 10.1016/j.tem.2019.05.008. Epub 2019 Jun 27.

Abstract

The microbiota has been identified as an important factor in health and in a variety of diseases. An altered microbiota composition increases the prevalence of Hashimoto's thyroiditis (HT) and Graves' disease (GD). Microbes influence thyroid hormone levels by regulating iodine uptake, degradation, and enterohepatic cycling. In addition, there is a pronounced influence of minerals on interactions between host and microbiota, particularly selenium, iron, and zinc. In manifest thyroid disorders, the microbiota may affect L-thyroxine uptake and influence the action of propylthiouracil (PTU). Although it is relatively well documented that thyroid disorders are linked to the composition of the microbiota, the role of specific genera and the potential use of therapies targeting the microbiota are less clear.

摘要

肠道菌群已被确定为健康和多种疾病的重要因素。肠道菌群组成的改变会增加桥本甲状腺炎(HT)和格雷夫斯病(GD)的患病率。微生物通过调节碘的摄取、降解和肠肝循环来影响甲状腺激素水平。此外,矿物质对宿主和微生物之间的相互作用有明显影响,特别是硒、铁和锌。在明显的甲状腺疾病中,微生物可能会影响 L-甲状腺素的摄取,并影响丙硫氧嘧啶(PTU)的作用。虽然有相当多的文献表明甲状腺疾病与肠道菌群的组成有关,但特定属的作用以及针对肠道菌群的治疗方法的潜在用途尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验